Arthur He
Stock Analyst at HC Wainwright & Co.
(3.60)
# 813
Out of 5,147 analysts
48
Total ratings
58.82%
Success rate
31.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Maintains: Buy | $135 → $165 | $68.98 | +139.20% | 6 | Feb 10, 2026 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $14.83 | +68.58% | 1 | Jan 7, 2026 | |
| VERA Vera Therapeutics | Maintains: Buy | $85 → $90 | $40.79 | +120.64% | 3 | Nov 10, 2025 | |
| ADAG Adagene | Maintains: Buy | $8 → $7 | $2.96 | +136.49% | 11 | Aug 15, 2025 | |
| AUPH Aurinia Pharmaceuticals | Assumes: Buy | $17 | $14.17 | +19.97% | 1 | Jul 30, 2025 | |
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $6.21 | +222.06% | 10 | Jun 17, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $4.62 | - | 8 | May 20, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.25 | - | 8 | Mar 31, 2025 |
Nektar Therapeutics
Feb 10, 2026
Maintains: Buy
Price Target: $135 → $165
Current: $68.98
Upside: +139.20%
Jade Biosciences
Jan 7, 2026
Initiates: Buy
Price Target: $25
Current: $14.83
Upside: +68.58%
Vera Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $85 → $90
Current: $40.79
Upside: +120.64%
Adagene
Aug 15, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.96
Upside: +136.49%
Aurinia Pharmaceuticals
Jul 30, 2025
Assumes: Buy
Price Target: $17
Current: $14.17
Upside: +19.97%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $6.21
Upside: +222.06%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.62
Upside: -
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.25
Upside: -